Back to results
US 2006/0142297 A1Published application
Combination product of inhibitor of the src family of non-recetpor tyrosine kinases and gemcitabine
OwnerAlan Bargeinventor
Life of this patent
Estimating the term…
Abstract
The invention concerns a combination comprising an inhibitor of Src kinase and the cytotoxic agent gemcitabine, a pharmaceutical composition comprising such a combination and its use in the treatment or prophylaxis of cancer, particularly of pancreatic cancer.
Claims10
A combination comprising an inhibitor of the Src family of non-receptor tyrosine kinases, or a pharmaceutically-acceptable salt thereof, and gemcitabine for use in the synergistic treatment or prophylaxis of cancer.
Dependencies are inferred from the claim text.